More specifically its focus is on areas such as kidney stone blasting via stone lasers/lithotripters, ultrasound infection control, guidance of needles or therapeutic instruments under ultrasound control as well as stabilisers and steppers to guide ultrasound procedures during Trans-Perineal Prostate Biopsies, Brachy-Therapy and/or MRI-Fusion Biopsies.
Meditron is now part of the Paragon Care Group
Paragon Care has progressively acquired businesses in the healthcare sector with a focus on those that distribute medical equipment, devices and consumables. Paragon Care Ltd’s (ASX:PGC) acquisition of Meditron, completed on 8 October 2015, represents a consistency with the Company’s strategy to become one of Australia’s leading providers of medical equipment and consumable products to the health and aged care sector throughout Australia and New Zealand.
